DK1272457T3 - Forbindelser til modulation af celleproliferation - Google Patents

Forbindelser til modulation af celleproliferation

Info

Publication number
DK1272457T3
DK1272457T3 DK01921087T DK01921087T DK1272457T3 DK 1272457 T3 DK1272457 T3 DK 1272457T3 DK 01921087 T DK01921087 T DK 01921087T DK 01921087 T DK01921087 T DK 01921087T DK 1272457 T3 DK1272457 T3 DK 1272457T3
Authority
DK
Denmark
Prior art keywords
compounds
cell proliferation
modulating cell
modulating
styrylacrylonitrile
Prior art date
Application number
DK01921087T
Other languages
Danish (da)
English (en)
Inventor
Chaim M Roifman
Thomas Grunberger
Olga Rounova
Peter Demin
Nigel Sharfe
Original Assignee
Hsc Res Dev Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsc Res Dev Lp filed Critical Hsc Res Dev Lp
Application granted granted Critical
Publication of DK1272457T3 publication Critical patent/DK1272457T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01921087T 2000-04-13 2001-04-12 Forbindelser til modulation af celleproliferation DK1272457T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19693600P 2000-04-13 2000-04-13

Publications (1)

Publication Number Publication Date
DK1272457T3 true DK1272457T3 (da) 2007-01-08

Family

ID=22727358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01921087T DK1272457T3 (da) 2000-04-13 2001-04-12 Forbindelser til modulation af celleproliferation

Country Status (18)

Country Link
US (3) US7012095B2 (pt)
EP (1) EP1272457B9 (pt)
JP (1) JP2003531133A (pt)
CN (1) CN100413845C (pt)
AT (1) ATE337296T1 (pt)
AU (2) AU4820101A (pt)
BR (1) BR0110087A (pt)
CA (1) CA2406160A1 (pt)
CY (1) CY1106447T1 (pt)
DE (1) DE60122484T2 (pt)
DK (1) DK1272457T3 (pt)
ES (1) ES2267747T3 (pt)
GB (1) GB2378948B (pt)
HK (1) HK1052496A1 (pt)
MX (1) MXPA02010089A (pt)
PT (1) PT1272457E (pt)
RU (1) RU2277531C9 (pt)
WO (1) WO2001079158A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406160A1 (en) 2000-04-13 2001-10-25 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
CA2463133A1 (en) * 2001-10-11 2003-04-17 The Hospital For Sick Children Styryl acrylonitrile compounds and their use to promote myelopoiesis
MXPA04006920A (es) * 2002-01-18 2005-06-17 Hospital For Sick Children Compuestos para modular la proliferacion celular.
WO2004032911A2 (en) * 2002-10-11 2004-04-22 The Hospital For Sick Children Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor
CH696238A5 (de) * 2003-06-30 2007-02-28 Lymphosign Inc Verfahren zur Herstellung von Zimtaldehydverbindungen.
US20070197660A1 (en) * 2003-07-30 2007-08-23 The Hospital For Sick Children Compounds for modulating cell proliferation
WO2005092904A1 (en) * 2004-03-26 2005-10-06 Hsc Research And Development Limited Partnership Novel compounds for modulating cell proliferation
US7202383B2 (en) 2004-09-14 2007-04-10 The Hospital For Sick Children Compounds useful for modulating abnormal cell proliferation
US7807719B2 (en) * 2004-09-14 2010-10-05 Chaim Roifman Compounds useful for modulating abnormal cell proliferation
JP5336082B2 (ja) 2004-10-25 2013-11-06 デック−テク インコーポレイテッド 抗腫瘍剤としてのイソホスホルアミドマスタードの塩及びその類似物
WO2007006143A1 (en) * 2005-07-13 2007-01-18 The Hospital For Sick Children Compositions and methods for detecting transformed cells
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
EP2043606A2 (en) * 2006-06-13 2009-04-08 Elan Pharma International Limited Nanoparticulate kinase inhibitor formulations
EP2155682B1 (en) 2007-04-06 2015-06-24 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof
US8450337B2 (en) * 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
WO2013027694A1 (ja) * 2011-08-24 2013-02-28 国立大学法人京都大学 コンフォメーション病診断用分子イメージングプローブ

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125597A (en) * 1964-03-17 chj oh
US2798881A (en) * 1954-11-12 1957-07-09 Du Pont 4-(aminoaryl)-1, 3-butadiene-2-carbonitriles and their preparation
US3047606A (en) * 1958-12-01 1962-07-31 Rohm & Haas Dialkyl 1-cyanovinylphosphonates, their preparation, and polymers and copolymers thereof
US3852683A (en) * 1971-10-18 1974-12-03 Eastman Kodak Co Arylidene dye lasers
GB1572441A (en) * 1975-12-23 1980-07-30 Vickers Ltd Photopolymerisable polymers with free carboxyl groups and printing plates therefrom
US4601532A (en) 1983-05-09 1986-07-22 Minnesota Mining And Manufacturing Company Narrow band light absorbing filter
US4554238A (en) * 1984-03-20 1985-11-19 Minnesota Mining And Manufacturing Company Spectrally-sensitized imaging system
JPS60244595A (ja) 1984-05-18 1985-12-04 Ricoh Co Ltd 感熱記録材料
US4632895A (en) 1984-08-23 1986-12-30 Minnesota Mining And Manufacturing Company Diffusion or sublimation transfer imaging system
US4617373A (en) 1985-02-15 1986-10-14 Eastman Kodak Company Condensation polymers and products therefrom
CA1275538C (en) 1985-08-16 1990-10-23 Wayne P. Pruett Colored unsaturated polyester material containing copolymerized methine dyes, and products therefrom
US4950467A (en) * 1986-11-14 1990-08-21 Ici Americas Inc. Ultraviolet radiation absorbing compositions
AU632992B2 (en) * 1987-12-24 1993-01-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
US5217999A (en) * 1987-12-24 1993-06-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Styryl compounds which inhibit EGF receptor protein tyrosine kinase
US5196147A (en) * 1988-03-28 1993-03-23 Teijin Limited Organic nonlinear optical substance
DE68911969T2 (de) 1988-03-28 1994-07-21 Teijin Ltd Organischer nichtlinearer optischer Stoff.
JPH02193954A (ja) 1989-01-23 1990-07-31 Teijin Ltd 薄膜規則性構造体
JP2672363B2 (ja) 1989-03-29 1997-11-05 帝人株式会社 有機非線形光学材料
JPH03230127A (ja) 1990-02-05 1991-10-14 Teijin Ltd 芳香族非線形光学材料
JPH03259126A (ja) 1990-03-09 1991-11-19 Teijin Ltd 新規な芳香族非線形光学材料
US5418245A (en) * 1990-04-16 1995-05-23 Rhone-Poulenc Rorer International (Holdings) Inc. Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US5196446A (en) * 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
JPH0436731A (ja) 1990-06-01 1992-02-06 Teijin Ltd 新規な芳香族系非線形光学材料
JPH0496026A (ja) 1990-08-13 1992-03-27 Teijin Ltd 非線形光学材料
DE59107068D1 (de) * 1990-09-17 1996-01-25 Ciba Geigy Ag Druck- oder wärmeempfindliches Aufzeichnungsmaterial
JPH04198924A (ja) 1990-11-29 1992-07-20 Teijin Ltd 芳香族共役基を有する非線形光学材料
JPH04214387A (ja) 1990-12-12 1992-08-05 Teijin Ltd 記録媒体及び記録方法
JP3342485B2 (ja) 1991-12-10 2002-11-11 塩野義製薬株式会社 芳香族スルホンアミド系ヒドロキサム酸誘導体
JPH05173206A (ja) 1991-12-20 1993-07-13 Teijin Ltd 配向非線形光学素子
JPH0695186A (ja) 1992-09-14 1994-04-08 Teijin Ltd 耐久性を有する非線形光学素子
JPH06135948A (ja) 1992-10-30 1994-05-17 Taiho Yakuhin Kogyo Kk スチレン誘導体又はその塩
US5763441A (en) 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5712395A (en) 1992-11-13 1998-01-27 Yissum Research Development Corp. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
US5792771A (en) 1992-11-13 1998-08-11 Sugen, Inc. Quinazoline compounds and compositions thereof for the treatment of disease
JPH06186599A (ja) 1992-12-16 1994-07-08 Teijin Ltd 配向安定性を有する非線形光学素子
IL107736A (en) 1993-11-24 2001-01-11 Yissum Res Dev Co Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
WO1995024190A2 (en) 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
US5656655A (en) * 1994-03-17 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
GB9406137D0 (en) * 1994-03-28 1994-05-18 Erba Carlo Spa N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
JP3230127B2 (ja) 1994-06-09 2001-11-19 三菱マテリアル株式会社 チップ材が高い接合強度を有する内燃機関タペット部材
CA2178914A1 (en) * 1994-07-27 1996-02-08 Yasunori Kitano Benzoylethylene derivative
JPH09230585A (ja) 1995-02-01 1997-09-05 Toray Ind Inc 水なし平版印刷版原版
WO1996040629A1 (en) 1995-06-07 1996-12-19 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
JP3259126B2 (ja) 1995-09-26 2002-02-25 富士通株式会社 リング伝送システム及び該システムのスケルチ方法
US5578416A (en) 1995-11-20 1996-11-26 Eastman Kodak Company Cinnamal-nitrile dyes for laser recording element
US5990193A (en) * 1995-12-12 1999-11-23 University Of Pittsburgh Polymers for reversible photoinduced sol gel transitions
US5932580A (en) * 1997-12-01 1999-08-03 Yissum Research And Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds their preparation and compositions
ES2226332T3 (es) * 1998-02-06 2005-03-16 De Montfort University Profarmacos activados mediante hidroxilacion.
CA2406160A1 (en) 2000-04-13 2001-10-25 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation

Also Published As

Publication number Publication date
EP1272457B9 (en) 2006-12-20
US20040209845A1 (en) 2004-10-21
ES2267747T3 (es) 2007-03-16
US6800659B2 (en) 2004-10-05
DE60122484T2 (de) 2006-12-21
WO2001079158A3 (en) 2002-01-31
WO2001079158A2 (en) 2001-10-25
RU2002127415A (ru) 2004-02-27
CN1429202A (zh) 2003-07-09
PT1272457E (pt) 2007-01-31
GB2378948B (en) 2004-11-10
CY1106447T1 (el) 2011-10-12
EP1272457A2 (en) 2003-01-08
GB0226316D0 (en) 2002-12-18
US20040072803A1 (en) 2004-04-15
EP1272457B1 (en) 2006-08-23
AU4820101A (en) 2001-10-30
ATE337296T1 (de) 2006-09-15
GB2378948A (en) 2003-02-26
AU2001248201B2 (en) 2006-12-14
RU2277531C2 (ru) 2006-06-10
US20030109502A1 (en) 2003-06-12
RU2277531C9 (ru) 2006-11-20
CA2406160A1 (en) 2001-10-25
JP2003531133A (ja) 2003-10-21
CN100413845C (zh) 2008-08-27
US7012095B2 (en) 2006-03-14
BR0110087A (pt) 2004-02-17
DE60122484D1 (de) 2006-10-05
HK1052496A1 (en) 2003-09-19
MXPA02010089A (es) 2004-08-19

Similar Documents

Publication Publication Date Title
DK1272457T3 (da) Forbindelser til modulation af celleproliferation
PL414997A1 (pl) Zastosowanie 40-O-(2-hydroksyetylo)-rapamycyny do leczenia guzów litych nerki
PL373645A1 (en) Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
TR200003514T2 (tr) Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri
HRP20050228A2 (en) Novel phenanthridines
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
EP1487428A4 (en) AMINO SUBSTITUTED (E) -2,6-DIALKOXY STYRYLENE 4-SUBSTITUTED BENZYL SULPHONES FOR THE TREATMENT OF PROLIFERATIVE ILLNESSES
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
BR0209149A (pt) Ftalazinonas
BR0109512A (pt) Imidazopiridinas tricìclicas
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
GB0517292D0 (en) Cell migration modulating compounds
DE60143023D1 (de) Tumorhemmende nitroacridin-zusammensetzungen
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
AU2002251873A1 (en) Methods and compositions for modulating gluconeogenesis using pgc-1
ATE364037T1 (de) Tryptasehemmer
WO2004038008A3 (en) Modulation of cellular proliferation
ATE238781T1 (de) Verwendung von katecholderivaten als proteinaseinhibitoren
UY24274A1 (es) Nuevos azepanes inhibidores de la proteína quinasa
ECSP003331A (es) Compuestos calciliticos